Endoscopic submucosal dissection for GI neoplasm in National Cancer Institute

Abstract

Background: Endoscopic Submucosal Dissection (ESD) has been proven to be effective procedure for therapeutic method for early gastrointestinal cancer due to able to obtain en-bloc resection. The study was aimed to investigate the lesions and outcomes.

Objective: To report outcomes of ESD cases in National Cancer Institute.

Material and methods: The retrospective study was carried out from November 2015 to July 2021.  22 patients, all of whom underwent ESD for GI neoplasm at department of surgery, National Cancer Institute, Bangkok ,Thailand. We investigated the following variables: patient characteristics, tumor location, tumor size, Pathological and histological features, recurrence and short-term survival outcome.

Results: From 22 ESD cases, 5 cases were diagnosed of Early GI cancer. The R0 resection was achieved 90.9% and outcomes has been observed which shown no tumor recurrence since follow up.

Conclusion: Endoscopic Submucosal Dissection is safe and provides favorable outcome for early GI cancers